Choosing blister films for Australian pharmaceutical production
The choice of blister film shapes every tablet's journey from press to patient, and in Australia that choice is shaped by climate, regulation, and a competitive generics market. A pack sold in Brisbane faces humidity that a sister product in Adelaide will rarely see, while a line running in western Sydney may package export batches destined for both tropical and temperate zones. Selecting the right thermoforming substrate is a strategic decision as much as a technical one, weighing barrier performance, patient convenience, machine compatibility, and the cost-per-pack that keeps a PBS-listed product viable.
Three families dominate the conversation: rigid PVC, PVdC-coated laminates, and aluminum cold-forming webs, often called ALU-ALU. Each occupies a different point on the moisture and oxygen protection spectrum, on machinability, and on end-user experience. Australian packagers know all three, but the choice is rarely driven by performance alone. Local realities, including elevated humidity along the eastern seaboard, TGA expectations around container closure systems, and the goal of a single SKU for domestic and export markets, all push selection in particular directions.
For stable, inexpensive drugs plain PVC remains the default. For moisture-sensitive products that still allow push-through convenience, PVdC coatings offer a middle path. For moisture-labile, oxygen-sensitive, or photosensitive molecules, including many newer generics and biologics arriving from contract development partners, aluminum cold-forming delivers the highest barrier available on a conventional blister line.
Walk-throughs of contract packagers in Melbourne and Brisbane show that most facilities run a mix of these substrates, often switching between PVC and ALU-ALU on the same thermoforming machine as schedules demand. The sections that follow break down each option, examine the Australian context that drives selection, and offer practical recommendations for matching film type to specific drug profiles.
Understanding blister film fundamentals
A blister pack is a multilayer system even when it looks simple. The base web is thermoformed into cavities that hold the dose, then sealed against a lidding foil, usually hard aluminum, with a heat-seal lacquer. The base web is where most of the protective work happens, and it is the substrate packagers change when moving between PVC, PVdC grades, and cold-form aluminum laminates. Barrier performance is measured in water vapour transmission rate (WVTR) and oxygen transmission rate (OTR). PVC sits at the porous end, allowing moisture to migrate through the cavity wall over months of storage, while PVdC coatings cut this transmission by a factor of roughly three to five, and aluminum cold-forming reduces it to near zero. Light protection follows a similar hierarchy.
Patient experience differs sharply across these films. PVC and PVdC allow push-through dispensing, where the patient presses the tablet through the foil lid. Cold-form packs cannot be push-through because the forming depth and aluminum layer make this impossible. They are peel-open only, which can confuse older patients and limits use where push-through is documented as a preference, including many PBS listings that specify the dosage form.
PVC rigid films
Rigid PVC, typically 250 µm thick for pharmaceutical blisters, is the workhorse of the industry. It is transparent, enabling visual inspection of the dose, and thermoforms at moderate temperatures on standard form-fill-seal equipment. Its barrier properties are modest, with a WVTR that rises sharply above 75 percent relative humidity, a regular condition along coastal Queensland during the wet season.
The economic appeal of PVC is hard to ignore. Material costs are a fraction of PVdC or aluminum laminates, and the forming window is forgiving, supporting high line speeds. Most generic tablet producers supplying Australia rely on PVC for stable molecules such as paracetamol, metformin, and common vitamins. For products with established stability data, including many long-listed PBS items made in Victoria and New South Wales, PVC delivers the lowest unit cost while meeting TGA container closure expectations. The downside appears when humidity pushes past 80 percent or when the active is hygroscopic; lactose-containing formulations, effervescent tablets, and some corticosteroids degrade faster in PVC packs stored in unconditioned warehouses or shipped through the tropics.
PVdC-coated films
PVdC-coated PVC, written PVC/PVdC, combines a rigid PVC core with a thin polyvinylidene chloride coating, typically 40 to 90 g/m². The coating does not change the forming behaviour much but substantially reduces water vapour transmission and improves oxygen barrier and light protection compared with plain PVC. PVdC grades also accept printing well, which matters for brand owners working with Sydney and Melbourne design studios that demand sharp retail graphics.
In practical terms PVdC extends shelf life by a factor that depends on the drug's sensitivity, often doubling or tripling the time before moisture content exceeds specification. This makes it sensible for products borderline in PVC, such as some oral contraceptives, certain antibiotics, and moisture-sensitive cardiovascular drugs. It still allows push-through dispensing, preserving the familiar patient experience. Cost sits between PVC and aluminum cold-forming, justified when stability work shows PVC failing accelerated humidity testing but the molecule tolerating short excursions. Several Australian generics manufacturers have shifted specific SKUs from PVC to PVdC after noticing in-house stability failures during summer months, particularly for products warehoused north of Rockhampton.
Aluminum cold-forming films
Aluminum cold-forming webs are multilayer laminates, most commonly oriented polyamide (OPA) on the outside, soft aluminum foil in the middle, and a PVC or PE sealing layer inside, often abbreviated OPA/AL/PVC. The web is formed at room temperature using matched metal tooling rather than heated plug assist. Because the aluminum layer is fully continuous, the cavity wall offers the highest moisture and oxygen barrier available in a blister pack, with WVTR values effectively at zero for practical shelf-life purposes.
Cold-forming delivers complete light protection and excellent chemical resistance, making it the substrate of choice for moisture-sensitive APIs, hormones, and biologics delivered as oral solid doses. Products such as levothyroxine, several antidepressants, and many proton pump inhibitors rely on ALU-ALU to maintain potency through long shipping routes and high-humidity climates. The packs are peel-open only, the forming cavity is larger than a comparable PVC cavity, and production is slower, requiring dedicated tooling and using more material per cavity. Cost per blister can run several times that of PVC, which is why ALU-ALU is reserved for products where the barrier justifies the price, particularly when the same formulation is sold into multiple climatic zones, a common scenario for Australian exporters shipping into South-East Asia, the Middle East, and Africa.
Australian climate and regulatory drivers
Australia spans climatic zones from tropical in the north to temperate in the south, with many population centres along the eastern coast sitting in the hot-humid category during summer. The Therapeutic Goods Administration evaluates container closure systems with these conditions in mind, referencing ICH Q1A stability data and often expecting real-time or accelerated testing at 30°C and 65 percent relative humidity as a baseline, with higher humidity for products destined for tropical distribution. Beyond climate, TGA expectations around the Australian Register of Therapeutic Goods (ARTG) require sponsors to hold stability data supporting the proposed packaging configuration; switching a registered PVC pack to PVdC or ALU-ALU triggers a need for bridging data or new stability studies, which discourages casual film changes.
Local manufacturing practice also matters. Australian GMP audits review formulation, processing, and packaging integrity, including forming temperature profile, sealing parameters, and in-process leak testing. Lines that run multiple substrates must be validated for each, and changeover between film types requires documented cleaning, set-up, and approval. These operational demands influence film selection because the cost of running a fourth or fifth SKU on a line can erode savings from a cheaper substrate.
Selecting the right film for your product
A structured selection process starts with the molecule. The aqueous degradation kinetics of the active, the hygroscopicity of the formulation, and the recommended storage conditions on the label define the barrier ceiling. A workable rule is to use PVC only when accelerated stability at 40°C and 75 percent RH passes with margin, PVdC when results are marginal but passing, and aluminum cold-forming when results fail or the label calls for protection from moisture and light.
Operational considerations refine the choice. Lines running shorter campaigns benefit from the forgiving forming window of PVC and PVdC, while lines dedicated to long runs of high-value products justify the slower throughput of cold-form. The decision also touches downstream equipment, since changeover discipline on packaging lines is a daily concern, and many facilities apply tube filling changeover principles to blister lines to keep downtime predictable across formats. Logistics close the loop. Products distributed widely across the country, especially to remote pharmacies in the Northern Territory and far north Queensland, benefit from the higher barrier of PVdC or ALU-ALU because cold chains break and warehouse conditions vary. Export-only SKUs almost always justify ALU-ALU, while domestic generics sold in tightly controlled urban distribution networks often remain in PVC.
| Property | PVC Rigid | PVdC-Coated PVC | Aluminum Cold-Form (ALU-ALU) |
|---|---|---|---|
| WVTR (approx.) | High | Moderate | Near zero |
| Oxygen barrier | Low | Moderate | Near zero |
| Light protection | None | Partial | Total |
| Patient opening | Push-through | Push-through | Peel-open only |
| Cost per cavity | Lowest | Mid | Highest |
| Typical line speed | Highest | Mid | Lowest |
| Climate suitability | Temperate, controlled | Variable | Tropical, export, sensitive APIs |
Practical recommendations for Australian packagers
- Map each SKU's stability profile to substrate options before committing to a registration, using ICH Q1A data plus local accelerated humidity work at 30°C and 65 percent RH.
- Reserve aluminum cold-forming for moisture-labile, oxygen-sensitive, or light-sensitive actives, especially where the same pack travels into tropical export markets.
- Use PVdC when a product sits between PVC and ALU-ALU on the barrier spectrum, treating it as a cost-effective upgrade for warehouse conditions in coastal Queensland and the Top End.
- Keep PVC for stable molecules with established data, ensuring forming and sealing parameters are validated under Australian GMP and that packaging-hall humidity stays below the threshold that affects web handling.
- Validate every film changeover with documented set-up, leak testing, and stability bridging, treating the substrate decision as a long-term packaging commitment rather than a quick cost exercise.